CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Announcing CRI’s Immunotherapy Patient Summit

    This fall, CRI is bringing something very new to our patient community: our first-ever Immunotherapy Patient Summit,…

    July 26, 2016| Emily Helck
  • Ready. Raise. Rise. for CRI!

    For the second year, CRI is participating in the Bristol-Myers Squibb Ready. Raise. Rise.™ Campaign to raise…

    July 22, 2016| Katherine McCluskey
  • CRI Scientist Receives Russian Federation National Award

    Sergei Nedospasov, PhD, D.Sc., was honored for his contributions to the molecular mediators of immunity, including work…

    July 13, 2016| Alexandra Mulvey
  • Have an Autoimmune Disease? You Still May Be Able To Receive Cancer Immunotherapy

    A retrospective study finds that immunotherapies are safe and work in many patients with preexisting autoimmune diseases.

    July 6, 2016| Alexandra Mulvey
  • CRI’s Answer to Cancer

    Just after dawn on Saturday, June 25, more than 200 cyclists began to gather in Highland Falls,…

    July 1, 2016| Katherine McCluskey
  • Immunotherapy 101? Ask a Scientist

    As part of Cancer Immunotherapy Month, Dr. Jeffrey Weber answers pressing questions from patients about cancer immunotherapy.

    June 29, 2016| CRI Staff
  • A “White Out” at the NBC TODAY Show Plaza

    On Monday, June 20, the Cancer Research Institute visited the NBC TODAY Show Plaza to raise public…

    June 20, 2016| Katherine McCluskey
  • ASCO 2016 Update: Tapping into the Potential of Anti-Tumor T Cells

    Adoptive T cell therapies provide success against some cancers, hope for several others.

    June 17, 2016| Arthur N. Brodsky, PhD
  • Together, we can #WhiteOutCancer!

    This year we’re on a mission to White Out Cancer—and we need your help!

    June 16, 2016| Katherine McCluskey
Previous Page
1 … 68 69 70 71 72 … 92
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute